Profile
Emmanuelle Charpentier is the founder of CRISPR Therapeutics AG, founded in 2013, and ERS Genomics Ltd., founded in 2014.
At ERS Genomics Ltd., she holds the title of Scientific Advisor, which she has held since 2014.
Emmanuelle Charpentier active positions
| Companies | Position | Start |
|---|---|---|
ERS Genomics Ltd.
 ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Founder | 01/01/2014 |
Former positions of Emmanuelle Charpentier
| Companies | Position | End |
|---|---|---|
| CRISPR THERAPEUTICS AG | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Private companies | 1 |
|---|---|
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology ERS Genomic Ltd. engages in the development of biotechnology. It was formed to provide broad access to the foundational CRISPR-Cas9, a new genome editing technology, which offers speed, efficiency, and cost over earlier genome editing methods. The company was founded by Emmanuelle Charpentier and Shaun Foy in 2014 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Emmanuelle Charpentier
